NeuroOne Medical (NMTC) Technologies Corporation announced that it has commenced a proposed underwritten registered public offering of shares of its common stock. All of the shares of common stock to be sold in the proposed offering will be sold by the company. Ladenburg Thalmann & Co. Inc. is acting as sole book-running manager for the proposed offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMTC:
- NeuroOne accelerates timeline of submission for OneRF trigeminal nerve ablation
- NeuroOne’s Earnings Call: Record Growth and Positive Outlook
- NeuroOne Reports Strong Revenue Growth in Q1 2025
- NeuroOne Medical sees FY25 product revenue $8M-$10M vs. $3.5M last year
- NeuroOne Medical reports Q1 EPS 6c vs. (14c) last year